1.05Open1.05Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover0.00%IV-4.65%PremiumSep 20, 2024Expiry Date1.07Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.42Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Bionano Genomics Stock Discussion
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
No comment yet